Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma
暂无分享，去创建一个
M. Boccadoro | A. Pileri | M. Ladetto | D. Caracciolo | P. Corradini | U. Vitolo | S. Vallet | F. Volpato | C. Tarella | S. Sametti | F. Zallio | A. Cuttica | A. Gianni | I. Ricca | M. Astolfi | P. Bondesan | Corrado Tarella | A. Pileri | Paolo Corradini | Francesco Zallio | Sonia Vallet | Daniele Caracciolo | Federica Volpato | A. M. Gianni